Risser Eric Blasius 4

4 · MACROGENICS INC · Filed Feb 17, 2026

AI-generated summary of this filing

Updated Feb 17, 2026

MacroGenics (MGNX) CEO Eric Risser Receives Awards, Exercises Options

What Happened

Eric Blasius Risser, President, CEO and Director of MacroGenics (MGNX), received two restricted stock unit (RSU) awards on Feb 12, 2026 totaling 695,000 RSUs (100,000 + 595,000). RSUs are derivative awards that convert into common shares on a one‑for‑one basis when they vest.
On Feb 15, 2026, 16,665 derivative shares converted/settled. Of those, 6,433 shares were disposed/withheld to cover tax withholding at approximately $1.71 per share for about $11,000; the net remaining converted shares retained are approximately 10,232.

Key Details

Transaction dates: RSU grants on 2026-02-12; conversion/settlement and tax withholding on 2026-02-15. Form 4 filed 2026-02-17.
Prices/values: RSU grants reported at $0.00 (derivative awards). Tax withholding disposal: 6,433 shares at $1.71 each, reported proceeds ~ $11,000.
Shares owned after transaction: Not specified in the provided filing excerpt.
Footnotes: F1–F3 describe prior and standard vesting terms — RSUs convert one‑for‑one to common stock; some grants/awards vest in installments (example: earlier 2023 RSU grant vested in thirds; other awards have staged vesting and exercisability schedules).
Filing timeliness: Form 4 was filed 2–5 days after the reported transactions (filed 2026-02-17 for transactions on 2026-02-12 and 2026-02-15). Insiders are generally required to file Form 4 within two business days of a reportable transaction; investors may want to check the official filing for any timeliness notation.

Context

These entries reflect award grants (RSUs) and a conversion/settlement event with shares withheld to cover tax liabilities — a common, administrative outcome when equity awards vest. RSU grants are not an immediate cash purchase and represent future potential shares as they vest.
The tax withholding (disposition of shares) is routine and does not necessarily indicate a view on the company’s stock. Purchases would typically signal a clearer bullish indicator; this filing primarily documents awards and routine tax withholding.

Form 4

Period: 2026-02-12

DirectorPresident and CEO

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-02-15+16,665→ 83,602 total
Tax Payment
Common Stock
2026-02-15$1.71/sh−6,433$11,000→ 77,169 total
Exercise/Conversion
Restricted Stock Unit
[F1]
2026-02-15−16,665→ 0 total
→ Common Stock (16,665 underlying)
Award
Restricted Stock Unit
[F2]
2026-02-12+100,000→ 100,000 total
→ Common Stock (100,000 underlying)
Award
Employee Stock Option (right to buy)
[F3]
2026-02-12+595,000→ 595,000 total
Exercise: $1.71Exp: 2036-02-12→ Common Stock (595,000 underlying)

Footnotes (3)

[F1]On February 15, 2023, the reporting person was granted 50,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis.
[F2]Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.
[F3]12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.

Signature

/s/ Beth A. Smith, Attorney-in-fact|2026-02-17

1 file